Ocera Therapeutics, Inc. Series C $35.5M

Posted in I - Series C, Q - 1Q08, R - WEST, X - GI

Ocera Therapeutics (San Diego, CA) a clinical stage company focused on gastrointestinal and liver diseases closed a $35.5M Series C financing. Participants include Montagu Newhall Associates, InterWest Partners, AgeChem Venture Fund, Cross Creek Capital, FinTech, CDIB BioScience, Domain Associates, Sofinnova Ventures and Thomas, McNerney & Partners.

Feb

2008

Gelesis, Inc.: Series A $16.0M

Posted in I - Series A, Q - 1Q08, R - NORTH EAST, X - GI, X - Obesity

Gelsis (Boston, MA) is developing a breakthrough treatment for obesity and other gastrointestinal disorders has closed a $16M Series A. Participants include OrbiMed, Queensland BioCapital Funds, PureTech Ventures, Lansing Brown Investments and the Cape Family Fund.

Mar

2007

Microbia, Inc.: Series F $50M

Posted in I - Series F, R - NORTH EAST, X - Cardiology, X - GI

Microbia (Cambridge, MA) rational drug designer focused on GI and cardiovascular therapeutics raised a $50M series F round. The financing was led by Ridgeback Capital and joined by Morgan Stanley Investment Management.

to top of page...